Updated Jul 16, 2026
Jordan Julie is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $18K.
Julie Jordan is a medical professional currently serving as the Chief Medical Officer at Neurogene Inc., a biotechnology company focused on developing gene therapies for neurological diseases. Her role involves overseeing clinical development and medical affairs.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-30 | NGNE | Neurogene Inc. | S — Open-market sale | 828 | $21.89 | $18K |
| 2026-02-24 | NGNE | Neurogene Inc. | A — Grant or award | 4.9K | $0.00 |
Julie Jordan is a medical professional currently serving as the Chief Medical Officer at Neurogene Inc., a biotechnology company focused on developing gene therapies for neurological diseases. Her role involves overseeing clinical development and medical affairs.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($18K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jordan Julie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.